e.salgado
Submits third-party assay reports on material purchased directly. Based in Salvador.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
99.34%
n=9
Suppliers covered
7
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041255 | Survodutide | WWB | WWB-2510-R2141 | Janoshik | 2026-Q1 | 98.61 | 5.74 | 91.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019172 | MK-677 (Ibutamoren mesylate) | TFC | TFC-2511-N5622 | Medutest | 2025-Q4 | 99.34 | 2.79 | 103.7 | Supplier-supplied | 1 | FAIL |
| AX-2025-019924 | IGF-1 LR3 | SWB | SWB-2505-N5257 | VendorInvestigate | 2025-Q4 | 96.06 | 6.70 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019580 | Semaglutide | Homopeptide | HOMO-2509-F1941 | PeptideMeter | 2025-Q4 | 99.93 | 4.88 | 96.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020640 | MOTS-c | SSA | SSA-2503-S7755 | Kestrel | 2025-Q3 | 99.20 | 5.11 | 103.3 | Laboratory-retained | 2 | FAIL |
| AX-2025-020693 | GHRP-6 | GL Biochem | GLBI-2503-A8778 | PeptideMeter | 2025-Q3 | 99.38 | 3.84 | 107.1 | Supplier-supplied | 2 | MARGINAL |
| AX-2024-004819 | Retatrutide | Homopeptide | HOMO-2407-P1771 | Medutest | 2024-Q3 | 98.49 | 6.11 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2024-005363 | GHRP-6 | CPC | CPC-2401-N2970 | Janoshik | 2024-Q2 | 99.43 | 5.66 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2024-004597 | Melanotan II | TFC | TFC-2401-J4881 | VendorInvestigate | 2024-Q2 | 99.59 | 3.95 | — | Buyer-sourced | 1 | MARGINAL |
| Supplier | Records | Median purity |
|---|---|---|
| TFC | 2 | n<3 |
| Homopeptide | 2 | n<3 |
| WWB | 1 | n<3 |
| SWB | 1 | n<3 |
| SSA | 1 | n<3 |
| GL Biochem | 1 | n<3 |
| CPC | 1 | n<3 |